The GLITTER Study 2 is a cluster randomized trial that will evaluate the impact of comprehensive and intensive management, comprising a team, technology, education, and peer resources, on metabolic control and psychological outcomes in patients with type 1 diabetes.
Members of the China Diabetes Type 1 Study (CD1S).
Experience in type 1 diabetes management: treat more than 50 T1D patients per year and have held camp activities at least once.
Have type 1 diabetes educators.
Diagnosis of Type 1 Diabetes.
Patients who plan to receive diabetes treatment at other hospitals.
Patients who have used an automated insulin delivery system or sensor-augmented pump within 3 months prior to screening.
Patients who refuse to use continuous glucose monitoring or insulin pumps, or refuse data upload and remote monitoring.
Patients with severe cardiovascular, cerebrovascular, hepatic, or renal diseases; uncontrolled systemic diseases, thyroid diseases; autoimmune diseases; or malignancies.